Amedisys Inc (AMED) Releases Quarterly Earnings Results
Amedisys Inc (NASDAQ:AMED) posted its quarterly earnings results on Tuesday. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.02, Bloomberg Earnings reports. The company had revenue of $380.20 million for the quarter, compared to analysts’ expectations of $384.59 million. Amedisys had a return on equity of 13.71% and a net margin of 2.70%. The firm’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.36 earnings per share.
Amedisys (NASDAQ:AMED) traded down $0.64 during midday trading on Tuesday, reaching $55.19. 453,620 shares of the company’s stock traded hands, compared to its average volume of 425,440. Amedisys has a 12-month low of $34.58 and a 12-month high of $65.91. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.21 and a current ratio of 1.21. The stock has a market cap of $1,870.00, a PE ratio of 29.00, a price-to-earnings-growth ratio of 1.34 and a beta of 0.68.
Several equities analysts have weighed in on AMED shares. Mizuho cut shares of Amedisys from a “buy” rating to a “neutral” rating and set a $50.00 price objective on the stock. in a research report on Wednesday, July 26th. BidaskClub cut shares of Amedisys from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Robert W. Baird reiterated a “hold” rating and set a $50.00 price objective on shares of Amedisys in a research report on Wednesday, October 4th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $60.00 price objective on shares of Amedisys in a research report on Friday, September 15th. Finally, SunTrust Banks, Inc. reiterated a “buy” rating and set a $60.00 price objective on shares of Amedisys in a research report on Monday, October 9th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Amedisys presently has an average rating of “Buy” and an average price target of $56.10.
ILLEGAL ACTIVITY WARNING: “Amedisys Inc (AMED) Releases Quarterly Earnings Results” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.thecerbatgem.com/2017/11/07/amedisys-inc-amed-releases-quarterly-earnings-results.html.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Receive News & Stock Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related stocks with our FREE daily email newsletter.